10th International Congress of the Immunology of Diabetes Society in Malm?,Sweden

第十届国际糖尿病学会免疫学大会在瑞典马尔姆举行

• 批准号: 7672586
• 负责人: AKE LERNMARK
• 金额: $ 2万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7672586
• 关键词: Address; Affect; Archives; Arts; Autoimmune Process; Autoimmunity; Belief; Beta Cell; Biological Assay; Blood Vessels; Centers for Disease Control and Prevention (U.S.); Child; Chronic Disease; Communities; Congresses; Diabetes Mellitus; Diabetes autoantibodies; Disease; Educational workshop; Etiology; Funding; Genetic; Grant; Immunology; Incidence; Individual; Injection of therapeutic agent; Insulin; Insulin-Dependent Diabetes Mellitus; International; Internet; Islets of Langerhans; Kidney; Life; Nerve; Oral; Pathogenesis; Patients; Preventive Intervention; Research; Research Personnel; Rest; Retina; Risk; Scholarship; Scientist; Societies; Standardization; Stream; Sweden; T-Lymphocyte; Time; Travel; United States National Institutes of Health; abstracting; lectures; meetings; posters; programs; symposium; web site

DESCRIPTION (provided by applicant): As the founding President of the Immunology of Diabetes Society and current co-chair of the Organizing Committee, Dr. Lernmark is submitting a grant to the National Institutes of Health for meeting support of the 10th International Congress of the Immunology of Diabetes Society (IDS) to be held in Malmoe, Sweden between Wednesday May 13 and Saturday May 16, 2009. This is a 3.5 day meeting that we expect to be attended by approximately 400 delegates from all over the world. The IDS is an international forum from all aspects of autoimmune type 1 diabetes - etiology- both genetic and environmental, pathogenesis, prediction, prevention, intervention and cure. International meetings are held under the IDS' auspice every 1.5 years. The last meeting was in Miami, FL in November, 2007. For this next meeting we are focusing on presenting recent advances in type 1 diabetes through key note address presentations, Symposia, Hot Topics, Debates, Oral presentations (10 min and 5 min discussion) and poster presentations the state of the art information within related fields. Oral presentations will be selected from submitted abstracts. There will be two workshops - one presenting results from the Diabetes Autoantibody Standardization Program (DASP) supported by the CDC and NIH and another about T cell Assay Standardization. The belief is that the diabetes immunology community will benefit much by sharing of information in the newest advances of other fields of research in immunology, genetics and autoimmunity. Hence the Key Address speakers are leading scientist in these fields of research. The organizing committee is planning to broadcast the lectures and presentations live on the internet. These lectures and presentations will also be archived and available on the conference website for a limited period of time streaming audio and on CD. More than half of the grant will be used to provide travel scholarships to young investigators. Travel grants for young investigators will be chosen by numerical ratings of submitted abstracts. Additional travel funding will be applied to Key Note address speakers, symposia speakers of Hot topics speakers chosen by the international organizing committee as outlined in the preliminary program. Type 1 diabetes, caused by an autoimmune attack on the pancreatic islet beta cells is the most common chronic disease in children. The incidence is increasing world-wide. There is no cure of type 1 diabetes and patients are dependent on daily insulin injections for the rest of their life-time. Every patients suffer the risk of late complications affecting the blood vessels, retina, kidney and nerves. It is a very expensive disease for the individual patient and for society.

描述（由申请人提供）：作为糖尿病免疫学学会的创始主席和组委会的现任联合主席，Lernmark博士向美国国立卫生研究院提交了一份赠款，用于支持将于2009年5月13日星期三至5月16日星期六在瑞典马尔默举行的第10届糖尿病免疫学学会国际大会（IDS）。这是一个为期3.5天的会议，我们预计将有来自世界各地的约400名代表参加。IDS是一个国际论坛，从自身免疫性1型糖尿病的各个方面-病因学-遗传和环境，发病机制，预测，预防，干预和治疗。国际会议每1.5年举行一次。最后一次会议是2007年11月在佛罗里达州的迈阿密举行的。在下一次会议上，我们将重点介绍1型糖尿病的最新进展，包括主题演讲、专题讨论会、热点话题、辩论、口头演讲（10分钟和5分钟讨论）和海报演讲，介绍相关领域的最新信息。口头报告将从提交的摘要中选出。将有两个研讨会-一个介绍由CDC和NIH支持的糖尿病自身抗体标准化计划（DASP）的结果，另一个是关于T细胞检测标准化。我们相信，糖尿病免疫学社区将通过分享免疫学，遗传学和自身免疫学研究其他领域的最新进展信息而受益匪浅。因此，演讲嘉宾是这些研究领域的领先科学家。组委会计划在互联网上直播讲座和演讲。这些讲座和演讲也将存档，并在有限的时间内通过音频流和CD在会议网站上提供。超过一半的赠款将用于为年轻的调查人员提供旅行奖学金。年轻研究人员的旅费赠款将根据提交的摘要的数字评级来选择。额外的差旅费将适用于国际组委会在初步计划中概述的主题演讲者、专题讨论会演讲者或热门主题演讲者。1型糖尿病是由胰岛β细胞的自身免疫攻击引起的，是儿童中最常见的慢性疾病。发病率在世界范围内不断上升。1型糖尿病是一种常见的糖尿病，它的主要症状是胰岛素抵抗。每个患者都有发生影响血管、视网膜、肾脏和神经的晚期并发症的风险。这是一个非常昂贵的疾病，为个人和社会。